| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EFTR | eFFECTOR Therapeutics, Inc. | Byrnes Michael | Chief Financial Officer | Nov 15, 2023 | Option Exercise | $0.50 | 4,524 | 2,250 | 43,271 | Nov 16, 2023, 05:26 PM | |
| EFTR | eFFECTOR Therapeutics, Inc. | Byrnes Michael | Chief Financial Officer | May 15, 2023 | Option Exercise | $0.46 | 4,863 | 2,232 | 38,747 | May 16, 2023, 08:01 AM | |
| EFTR | eFFECTOR Therapeutics, Inc. | Byrnes Michael | Chief Financial Officer | Nov 15, 2022 | Option Exercise | $0.47 | 4,651 | 2,179 | 33,884 | Nov 16, 2022, 06:30 PM | |
| EFTR | eFFECTOR Therapeutics, Inc. | Byrnes Michael | Chief Financial Officer | Jun 07, 2022 | Buy | $1.33 | 25,000 | 33,263 | 29,233 | Jun 07, 2022, 05:30 PM | |
| EFTR | eFFECTOR Therapeutics, Inc. | Byrnes Michael | Chief Financial Officer | May 13, 2022 | Option Exercise | $1.53 | 4,233 | 6,476 | 4,233 | May 17, 2022, 08:46 PM | |
| OCRX | Ocera Therapeutics, Inc. | Byrnes Michael | CFO and Treasurer | Dec 11, 2017 | Option Exercise | $1.52 | 163,000 | 247,760 | 0 | Dec 11, 2017, 03:23 PM | |
| OCRX | Ocera Therapeutics, Inc. | Byrnes Michael | CFO and Treasurer | Mar 28, 2017 | Buy | $1.28 | 3,000 | 3,854 | 13,000 | Mar 28, 2017, 04:06 PM | |
| OCRX | Ocera Therapeutics, Inc. | Byrnes Michael | CFO and Treasurer | Jan 15, 2016 | Buy | $2.07 | 3,500 | 7,245 | 10,000 | Jan 19, 2016, 08:14 AM | |
| OCRX | Ocera Therapeutics, Inc. | Byrnes Michael | CFO and Treasurer | May 06, 2015 | Buy | $3.61 | 2,500 | 9,025 | 6,500 | May 06, 2015, 06:03 PM | |
| OCRX | Ocera Therapeutics, Inc. | Byrnes Michael | VP, Finance & Treasurer | Oct 01, 2014 | Buy | $4.81 | 2,000 | 9,620 | 4,000 | Oct 02, 2014, 04:16 PM |
Menu